Reema Panjwani

Title: Reema Panjwani: Innovator in Cancer Treatment

Introduction

Reema Panjwani is a notable inventor based in Bayside, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patent.

Latest Patents

Reema holds a patent for "Methods of treating cancer using cell-based therapies." This patent discloses compositions and methods aimed at reversing senescence in T cells by interrupting vasoactive intestinal peptide (VIP) signaling and/or inhibiting phosphatidylinositol-3-kinase (PI3 kinase) inhibitor signaling. The methods outlined in her patent are designed to manage cancer and chronic viral infections. In certain embodiments, the disclosure contemplates methods of reversing T cell senescence by mixing T cells in vitro with an agent that prevents VIP from interacting with VIP receptors and/or a PI3 kinase inhibitor. Additionally, the patent discusses the expansion of senescent T cells by mixing them with a PI3 kinase inhibitor, an agent that blocks VIP and VIP receptor signaling, a VIP degrading enzyme, and combinations thereof.

Career Highlights

Reema is affiliated with Emory University, where she continues her research and development in the field of cancer therapies. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Reema collaborates with esteemed colleagues such as Edmund K. Waller and Anna Morris, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

Reema Panjwani's contributions to cancer treatment through her patented methods highlight her role as a leading inventor in the medical field. Her work not only advances scientific knowledge but also holds the potential to significantly impact patient care.